Clinical Summary

Clinical Summary: How Many Criteria Should Be Required to Define the DSM-5 Mixed Features Specifier in Depressed Patients?

Depressed patients with manic symptoms carry higher clinical risk and different treatment implications, including concern about antidepressant use when mixed features are present. This study asks a practical diagnostic question: would lowering the DSM-5-TR mixed-features threshold from 3 symptoms to 2 identify clinically similar patients, or would it overbroaden the diagnosis?

Design we compare 3 groups of depressed patients: 0–1 DSM-5-TR mixed features, 2 mixed features, and 3 or more mixed features (the DSM-5-TR threshold)
N Four hundred fifty-nine patients
Population patients with current DSM-IV/DSM-5-TR MDD or bipolar disorder (current episode depressed) presenting for an intake evaluation at the Rhode Island Hospital Department of Psychiatry partial hospital program
Setting the Rhode Island Hospital Department of Psychiatry partial hospital program

Key Findings

  • Only 3.9% (n=18) of the entire sample of depressed patients met the DSM-5-TR criteria for the mixed features specifier for the majority of the depressive episode, while 9.4% (n=43) met criteria during the week before the assessment.
  • Lowering the diagnostic threshold from 3 to 2 criteria increased prevalence from 3.9% to 13.1% (n=60) using the majority of episode time frame and from 9.4% to 22.9% (n =105) using a past week time frame.
  • Patients with bipolar disorder were significantly more likely than patients with MDD to meet the mixed features specifier at the DSM-5-TR 3-symptom threshold (29.8% vs. 9.2%; OR 4.18; 95% CI, 2.06–8.48).
  • When the threshold was lowered to 2 or more mixed features, bipolar disorder remained more likely than MDD to meet criteria (48.9% vs. 24.8%; OR 2.91; 95% CI, 1.58–5.38), but when analysis was limited to patients with only 2 mixed features, the difference was not significant (19.1% vs. 15.5%; OR 1.29; 95% CI, 0.59–2.79).
  • In patients with MDD, those with 2 mixed features did not differ from patients without mixed features in functioning, age of onset, history of psychiatric hospitalization, family history of bipolar disorder, frequency of comorbid disorders, or lifetime suicide attempts; compared to patients with 3 or more mixed features, they had a significantly lower prevalence of social anxiety disorder, borderline personality disorder, and attention deficit disorder.
Clinical Bottom Line

Do not lower the DSM-5-TR mixed-features threshold in depressed patients from 3 symptoms to 2. A 2-symptom cutoff increases case capture substantially but does not preserve the clinical profile that supports the validity of the current specifier.

Practice Implications

  • Use the current 3-symptom DSM-5-TR threshold when diagnosing mixed features in depressed patients rather than expanding the diagnosis to patients with exactly 2 symptoms.
  • Interpret prevalence estimates in light of the assessment window: rates were 3.9% for the majority of the episode and 9.4% for the past week, so time frame materially affects how often mixed features are identified.
  • When a depressed patient reports exactly 2 DSM-5 mixed-feature symptoms, assess severity carefully, but do not assume the broader bipolar-linked validators seen with 3 or more symptoms.
  • Be cautious about changing treatment solely on the basis of 2 mixed features, since this group did not show the same diagnostic discrimination between bipolar disorder and MDD as patients meeting the 3-symptom threshold.
Read full article
Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.